TrademarkDir
ENRICH EXCELLENCE NETWORK IN RHEUMATOLOGY TO INNOVATE CARE AND HIGH-IMPACT RESEARCH
LIVE

Serial Number

99257653

Owner

Foundation for Advancing Science, Technology, Education and Research

First Use Date

Jun 27, 2025

Filing Date

Jun 27, 2025

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ENRICH EXCELLENCE NETWORK IN RHEUMATOLOGY TO INNOVATE CARE AND HIGH-IMPACT RESEARCH Trademark

Serial Number: 99257653 • Registration: 8340972

ENRICH EXCELLENCE NETWORK IN RHEUMATOLOGY TO INNOVATE CARE AND HIGH-IMPACT RESEARCH is a trademark filed by Foundation for Advancing Science, Technology, Education and Research on June 27, 2025. The trademark is classified under Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Foundation for Advancing Science, Technology, Education and Research (2 trademarks)

3000 Riverchase Galleria
Hoover, AL 35244

Entity Type: 03

Trademark Details

Filing Date

June 27, 2025

Registration Date

July 14, 2026

First Use Anywhere

June 27, 2025

First Use in Commerce

June 27, 2025

Published for Opposition

May 26, 2026

Goods & Services

Association services, namely, promoting the interests of healthcare providers and researchers

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 14, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 14, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 26, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 26, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 20, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 30, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 23, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 23, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 23, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 23, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 27, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 27, 2026 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 27, 2026 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 26, 2026 GNFN
FINAL REFUSAL E-MAILED
Mar 26, 2026 GNFR
FINAL REFUSAL WRITTEN
Mar 26, 2026 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 21, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 20, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 20, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 24, 2025 GNRN
NON-FINAL ACTION E-MAILED
Nov 24, 2025 GNRT
NON-FINAL ACTION WRITTEN
Nov 24, 2025 CNRT
ASSIGNED TO EXAMINER
Nov 17, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 6, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 6, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jun 27, 2025 MAFR
NEW APPLICATION ENTERED
Jun 27, 2025 NWAP

Related Trademarks

More from this Owner

ENRGY EXCELLENCE NETWORK IN RHEUMATOLOGY logo

ENRGY EXCELLENCE NETWORK IN RHEUMATOLOGY

ENRGY EXCELLENCE NETWORK IN RHEUMATOLOGY logo

ENRGY EXCELLENCE NETWORK IN RHEUMATOLOGY

ENRGY EXCELLENCE NETWORK IN RHEUMATOLOGY logo

ENRGY EXCELLENCE NETWORK IN RHEUMATOLOGY

EXCELLENCE NETWORK IN RHEUMATOLOGY TO INNOVATE CARE AND HIGH-IMPACT RESEARCH (ENRICH)

EXCELLENCE NETWORK IN RHEUMATOLOGY TO INNOVATE CARE AND HIGH-IMPACT RESEARCH (ENRICH)

EXCELLENCE NETWORK IN RHEUMATOLOGY TO INNOVATE CARE AND HIGH-IMPACT RESEARCH (ENRICH)

EXCELLENCE NETWORK IN RHEUMATOLOGY TO INNOVATE CARE AND HIGH-IMPACT RESEARCH (ENRICH)

EXCELLENCE NETWORK IN RHEUMATOLOGY TO INNOVATE CARE AND HIGH-IMPACT RESEARCH (ENRICH)

EXCELLENCE NETWORK IN RHEUMATOLOGY TO INNOVATE CARE AND HIGH-IMPACT RESEARCH (ENRICH)